Sickle cell disease (SCD) is a group of inherited autosomal recessive disorders, including
sickle cell anemia, sickle beta-thalassemia, and other hemoglobinopathies, which are …

Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has
emerged as an important toxicity among patients with cancer. Methods We collected data on …

The number of individuals with the sickle cell trait exceeds 300 million worldwide, making
sickle cell disease one of the most common monogenetic diseases globally. Because of the …

Sickle cell disease (SCD) is the most-common monogenic recessive disease in humans,
annually affecting almost 300,000 newborns worldwide, 75% of whom live in Africa …

Sickle cell disease (SCD) is a group of inherited blood disorders affecting the β-globin gene,
resulting in the polymerization of hemoglobin and subsequent sickling of the red blood cell …

Although descriptions of quality of life and patient reports of mood in sickle cell disease
(SCD) have become more common in the literature, less is known about psychiatric illness …

Background: Sickle cell trait affects∼ 8% of African American individuals, along with many
other individuals with ancestry from malaria-endemic regions worldwide. While traditionally …

Sickle cell nephropathy (SCN) is a leading cause of morbidity and mortality in sickle cell
disease (SCD). Early intervention is crucial for mitigating its effects. However, current …

Sickle cell disease (SCD) affects∼ 100 000 predominantly African American individuals in
the United States, causing significant cellular damage, increased disease complications …

Objectives: Outline the pathophysiology of sickle cell crisis. Review the complications of
sickle cell disease. Outline the treatment and management options available for sickle cell …